Acute Congestive Heart Failure Urgent Care Evaluation
Completed
- Conditions
- Heart Failure
- Registration Number
- NCT02634762
- Lead Sponsor
- Institute for Clinical Evaluative Sciences
- Brief Summary
This prospective validation study evaluates the ability of a risk algorithm, which can simultaneously predict the risk of death at 7 days and 30 days for patients with acute heart failure presenting to the emergency department. The risk algorithms for prediction of 7-day (Emergency Heart failure Mortality Risk Grade \[EHMRG\]) and 30-day mortality (EHMRG30-ST) have been previously derived.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1983
Inclusion Criteria
- Patients with acute heart failure diagnosed in the emergency department
Exclusion Criteria
- Palliative or do-not-resuscitate (DNR) directive
- Dialysis dependent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality 30 days Death within 30 days after emergency department presentation for heart failure
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers underlie the EHMRG algorithm's 7-day mortality prediction in acute heart failure patients?
How does the EHMRG30-ST score compare to existing risk models like ADHERE for 30-day mortality in ED heart failure cases?
Which clinical biomarkers (e.g., BNP, NT-proBNP) are most critical for patient stratification in the NCT02634762 risk algorithms?
What adverse event profiles are associated with high-risk acute heart failure patients identified by the EHMRG algorithm?
Are there novel therapeutic targets or combination strategies validated alongside EHMRG risk scores for acute decompensated heart failure management?
Trial Locations
- Locations (1)
University Health Network
🇨🇦Toronto, Ontario, Canada